News | Artificial Intelligence | November 05, 2022

Guerbet announced an agreement with Merative, formalizing the termination of their collaboration signed in July 2018

Guerbet announced an agreement with Merative, formalizing the termination of their collaboration signed in July 2018.

Nov. 4, 2022 — Guerbet announced an agreement with Merative formalizing the termination of their collaboration initiated in July 2018. This partnership aimed to design, develop and market software solutions to help diagnose and monitor liver and prostate cancers. The termination follows Merative's strategic shift in how it delivers artificial intelligence within its imaging product portfolio.The new Asset Assignment and License Agreement grants Guerbet the ability and autonomy to pursue research and development, and plan for the market launch of artificial intelligence solutions. Assets developed during the partnership, including source code for application software, Artificial Intelligence algorithms and the associated intellectual property, are being transferred to Guerbet. The market potential remains unchanged and significant, and this Asset Assignment and License Agreement will transfer control over the remaining development work to Guerbet. Promising initial results have been obtained in 2022, particularly for the detection of liver lesions (presentation scheduled for the RSNA 2022 conference) and for the detection of prostate cancer (work presented at the ECR 2022 conference). The high quality of the work presented by Guerbet’s Artificial Intelligence research team also impressed the jury of the BPI France 2030 program, which has awarded the company €1 million in funding for its project aimed at early detection of pancreatic cancer, as recently announced. Numerous stakeholders have communicated their interest to the Group’s management in recent months, attesting to the business’ strong potential. Constructive discussions are currently also underway to set up new partnerships in order to accelerate the business roadmap and to facilitate the emergence of a national champion in the area of artificial intelligence for medical imaging.

For more information: www.guerbet.com

Find more RSNA22 coverage here 


Related Content

News | Computed Tomography (CT)

November 30, 2022 — NeuroLogica Corp., a subsidiary of Samsung Electronics Co. Ltd., announced that its head-to-toe ...

Time November 30, 2022
arrow
News | Virtual and Augmented Reality

November 30, 2022 — GE Healthcare, a leading global medical technology, pharmaceutical diagnostics and digital solutions ...

Time November 30, 2022
arrow
News | Artificial Intelligence

November 30, 2022 — Ziosoft, a pioneer in 3D/4D AI medical visualization, is introducing its newest software for its ...

Time November 30, 2022
arrow
News | RSNA

November 30, 2022 — Findings from four separate studies on long-term impacts of COVID-19 were presented during a ...

Time November 30, 2022
arrow
News | Ultrasound Imaging

November 30, 2022 — A minimally invasive treatment for carpal tunnel syndrome provides complete and long-term relief to ...

Time November 30, 2022
arrow
News | Computed Tomography (CT)

November 30, 2022 — Using a decade of weather and CT imaging data, researchers have identified specific weather ...

Time November 30, 2022
arrow
Feature | RSNA | Christine Book

November 29, 2022 — It was only fitting that on Giving Tuesday, the RSNA 2022 5k Fun Run kicked off the third day of the ...

Time November 29, 2022
arrow
Feature | Radiology Education | Christine Book

November 29, 2022 — Two panel discussions held Nov. 29, during the second day of the 108th Radiological Society of North ...

Time November 29, 2022
arrow
News | Artificial Intelligence

November 29, 2022 — ScImage, Inc., a leading provider of Cloud-native enterprise imaging and reporting solutions for all ...

Time November 29, 2022
arrow
News | Artificial Intelligence

November 29, 2022 — Quantivly is highlighting new advances in its artificial intelligence (AI)-driven software for ...

Time November 29, 2022
arrow
Subscribe Now